Hiromachi, Japan

Yuichiro Yabe


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 152(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Hiromachi, JP (1978 - 1995)
  • Tokyo, JP (1987 - 1997)

Company Filing History:


Years Active: 1977-1997

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Yuichiro Yabe: Innovator in Pharmaceutical Chemistry

Introduction

Yuichiro Yabe is a prominent inventor in the field of pharmaceutical chemistry, known for his significant contributions to the development of compounds that target critical health issues. He is based in Hiromachi, Japan, and has been awarded a total of 8 patents for his innovative work.

Latest Patents

Among his latest patents, Yabe has developed inhibitors of HIV protease, which are compounds designed to inhibit the activity of HIV protease and may be used for the treatment and prophylaxis of AIDS. These compounds include various functional groups that enhance their efficacy. Additionally, he has worked on peptides that exhibit renin inhibitory activity, which are valuable in diagnosing and treating hypertension induced by failures in the renin-angiotensin system.

Career Highlights

Yuichiro Yabe is associated with Sankyo Company, Limited, where he has made significant strides in pharmaceutical research and development. His work has not only advanced scientific understanding but has also contributed to potential therapeutic solutions for serious health conditions.

Collaborations

Throughout his career, Yabe has collaborated with notable colleagues, including Tatsuo Kokubu and Kunio Hiwada, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Yuichiro Yabe's innovative contributions to pharmaceutical chemistry highlight his role as a key inventor in the field. His work continues to influence the development of important medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…